IFN-α induces APOBEC3G, F, and A in immature dendritic cells and limits HIV-1 spread to CD4+ T cells

J Immunol. 2013 Apr 1;190(7):3346-53. doi: 10.4049/jimmunol.1201184. Epub 2013 Feb 20.

Abstract

Cytokines and IFNs, such as TNF-α and IFN-α, upregulate costimulatory molecules in monocyte-derived dendritic cells (MDDCs), enabling effective Ag presentation to T cells. This activation of MDDCs is often accompanied by upregulation of apolipoprotein B mRNA-editing, enzyme-catalytic, polypeptide-like 3 (APOBEC3) (A3) family proteins that are able to restrict HIV-1 replication in MDDCs by inducing hypermutations in the viral genome. In this study, we show that TNF-α upregulates costimulatory molecules and are able to restrict HIV-1BaL replication in MDDCs without significant induction of A3G, A3A, or A3F. Conversely, low quantities of IFN-α failed to upregulate costimulatory molecules, did not induce IL-12p40 or migration, but significantly induced A3G, A3A, and A3F mRNA expression and restricted viral replication in MDDCs. We also showed that transmission of HIV-1 from MDDCs to autologous T cells was significantly reduced in the presence of IFN-α. Sequence analyses detected the induction of high frequency of G-to-A hypermutations in the env genes from HIV-1BaL-infected MDDCs treated with low quantities of IFN-α2b. These findings show that low quantities of IFN-α can induce functional A3 family proteins and restrict HIV-1 replication in MDDCs while keeping an immature nonmigratory phenotype, supporting further investigations of modalities that enhance retroviral restriction factors. In addition, the findings highlight the role of IFN-α as a double-edged sword in HIV-1 infection, and we show that IFN-α can be powerful in reducing HIV-1 infection both in MDDCs and T cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • APOBEC-3G Deaminase
  • B7-1 Antigen / metabolism
  • B7-2 Antigen / metabolism
  • Bone Marrow Cells / drug effects
  • Bone Marrow Cells / immunology
  • Bone Marrow Cells / metabolism
  • CD4-Positive T-Lymphocytes / drug effects*
  • CD4-Positive T-Lymphocytes / immunology
  • CD4-Positive T-Lymphocytes / virology*
  • Cell Movement / immunology
  • Cells, Cultured
  • Cytidine Deaminase / genetics
  • Cytidine Deaminase / metabolism*
  • Cytosine Deaminase / genetics
  • Cytosine Deaminase / metabolism
  • Dendritic Cells / drug effects*
  • Dendritic Cells / immunology
  • Dendritic Cells / metabolism*
  • Gene Expression Regulation / drug effects
  • HIV-1 / physiology*
  • Humans
  • Interferon alpha-2
  • Interferon-alpha / pharmacology*
  • Mutation / drug effects
  • Polyethylene Glycols / pharmacology
  • Proteins / genetics
  • Proteins / metabolism
  • Recombinant Proteins / pharmacology
  • Tumor Necrosis Factor-alpha / pharmacology
  • Virus Replication / drug effects
  • env Gene Products, Human Immunodeficiency Virus / genetics

Substances

  • B7-1 Antigen
  • B7-2 Antigen
  • Interferon alpha-2
  • Interferon-alpha
  • Proteins
  • Recombinant Proteins
  • Tumor Necrosis Factor-alpha
  • env Gene Products, Human Immunodeficiency Virus
  • Polyethylene Glycols
  • APOBEC3F protein, human
  • Cytosine Deaminase
  • APOBEC-3G Deaminase
  • APOBEC3A protein, human
  • APOBEC3G protein, human
  • Cytidine Deaminase
  • peginterferon alfa-2b